Methods developed and validated to establish the “World Bank of NK Cells” from healthy donors and cancer patientsSingle ...

In this webinar, Stefan Radtke will discuss the development of new high-throughput single-cell readouts for precise and comprehensive tracking of gene editing outcomes after autologous hematopoietic ...

New data supports GraftAssure commercialization effortsMulti-center study featured 249 biopsy-matched patientsProprietary "Combination Model" score outperformed percentage-only measures of dd-cfDNARei ...

The investigators found that dd-cfDNA levels increased with histological evidence of graft inflammation, with the strongest associations observed in microvascular inflammation (MVI) and ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals ...

In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...

As non-animal models move mainstream, the focus is shifting toward reproducibility and data integrity. By using specialized ...

Researchers analyzed molecular sensitization patterns in Polish patients with perennial allergic rhinitis who tested positive for cockroach allergens. They found that most apparent cockroach allergies ...

The "Micro Electrode Array Market - Growth, Share, Opportunities & Competitive Analysis, 2025 - 2032" report has been added to the Credence Research Inc.

This quarter, MindWalk Holdings Corp. reported its third consecutive year-over-year revenue increase and advanced three pipeline programs toward data readouts. In addition, we recently signed our ...

Thank you for joining us today for MindWalk Holdings Corp.'s Third Quarter Fiscal Year 2026 Earnings Call. MindWalk trades on the NASDAQ under the ticker HYFT. Today's call will be led by our Chief ...

ELRIG, a not-for-profit, volunteer-led organisation dedicated to the global drug discovery community, today announced the ...